Rituximab in life threatening antisynthetase syndrome

Rheumatology International

Volumn 29, Issue 12, 2009, Pages 1499-1502

  Vandenbroucke, E ^a   Grutters, J C ^b   Altenburg, J ^c   Boersma, W G ^c   Ter Borg, E J ^b   Van Den Bosch, J M M ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c Location Alkmaar   (Netherlands)

Author keywords

Anti Jo 1; Anti Ro SSA; Antisynthetase syndrome; Interstitial pneumonitis; PET scan; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR ALPHA; JO 1 ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; MUSCLE BIOPSY; OXYGEN SATURATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYOSITIS; RECEPTORS, INTERLEUKIN-2; SYNDROME; TREATMENT OUTCOME;

EID: 69049099961     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0859-x     Document Type: Article

References (11)

1. A Imbert-Masseau M Hamidou C Agard J-Y Grolleau P Chérin 2003 Antisynthetase syndrome Joint Bone Spine 70 161 168 10.1016/S1297-319X(03)00012- 5
2. I Marie E Hachulla P Chérin, et al. 2002 Interstitial lung disease in polymyositis and dermatomyositis Arthritis Rheum 47 614 622 10.1002/art.10794
3. R La Corte A Lo Mo Naco A Locaputo F Dolzani R Trotta 2006 In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease Autoimmunity 39 249 253 10.1080/08916930600623791
4. HK Chang DH Lee 2003 Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody J Korean Med Sci 18 131 134
5. M Jankowska B Butto A Debska-Slizien B Rutkowski 2007 Beneficial effect of treatment with cyclosporine A in a case of refractory antisynthetase syndrome Rheumatol Int 27 775 780 10.1007/s00296-006-0289-y
6. L Bulhart J-M Waldburger C Gabay 2006 Rituximab in the treatment of antisynsthetase syndrome Ann Rheum Dis 65 974 975 10.1136/ard.2005.045898
7. TD Levine 2005 Rituximab in the treatment of dermatomyositis. An open-label pilot study Arthritis Rheum 52 601 607 10.1002/art.20849
8. O Lambotte R Koth G Maigne F-X Blanc C Goujard J-F Delfraissy 2005 Efficacy of rituximab in refractory polymositis J Rheumatol 32 1369 1370
9. CC Mok LY Ho CH To 2007 Rituximab for refractory polymyositis: an open label prospective study J Rheumatol 34 1864 1868
10. GJ Silverman S Weisman 2003 Rituximab therapy and autoimmune disorders. Prospects for anti-B cell therapy Arthritis Rheum 48 1484 1492 10.1002/art.10947
11. JC Edwards L Szczepanski J Szechinski, et al. 2004 Efficacy of B-cell-Targeted Therapy with Rituximab in Patients with Rheumatoid Arthirtis N Engl J Med 350 2572 2581 10.1056/NEJMoa032534